“…This results with newly formed bone being disorganized (woven) and mechanically weaker, overall resulting in skeletal lesions with abnormal bone architecture (Shaw et al, 2019). Typically, PDB affects one (monostotic) or more (polyostotic) skeletal elements, with research supporting a higher prevalence of the monostotic type of this disease (Winn, Lalam, & Cassar-Pullicino, 2016). Although PDB can affect any bone in the human skeleton, it is most frequently reported to affect the axial skeleton (e.g., skull, lumbar spine, pelvis, sacrum, femur and tibia; see Cundy, 2018;Ralston et al, 2019), and despite a steady decrease in secular changes (Abdulla, Naqvi, Shamshuddin, Bukhari, & Proctor, 2018), it is one of the most common metabolic bone disorders after osteoporosis (Vallet & Ralston, 2016).…”